The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-5D MDS: Clinical

Sun. Oct 14, 2018 3:00 PM - 4:00 PM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Tomoko Hata (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Japan)

[OS3-5D-2] Strongly positive CD41 blasts are a poor prognostic factor for MDS treated with azacitidine

Akihito Matsuoka1, Masaki Tanibuchi2, Teruhisa Taoka1 (1.Dept., Hematol., Sakaide City Hospital, Kagawa, Japan, 2.Dept., Laboratory Medicine, Sakaide City Hospital, Kagawa, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password